Skip to search formSkip to main contentSkip to account menu
Epidemiological features of Kawasaki disease in Korea, 2006–2008
Background:  The aim of this study was to estimate the incidence and describe the epidemiological characteristics of Kawasaki disease among children in Korea.
View on Wiley
The Causative Organisms of Bacterial Meningitis in Korean Children in 1996-2005
TLDR
S. agalactiae, S. pneumoniae and H. influenzae were important etiologic agents of bacterial meningitis in children in the last 10 yrs, and it is required to establish the preventive strategy of the three bacteria.
View PDF
The Immunogenicity and Safety of the Live-attenuated SA 14-14-2 Japanese Encephalitis Vaccine Given with a Two-dose Primary Schedule in Children
TLDR
The 2-dose administration of LAJEV in the primary immunization schedule appeared to be highly immunogenic and safe.
View PDF
Safety and Immunogenicity of a New Trivalent Inactivated Split-virus Influenza Vaccine in Healthy Korean Children: A Randomized, Double-blinded, Active-controlled, Phase III Study
  • J. Kang, C. Oh, H. Lee
  • Medicine
    Journal of Korean medical science
  • 27 October 2011
TLDR
GC501 vaccine has good tolerability and favorable immunogenicity in children aged 6 months to < 18 yr and the addition of one more brand of influenza vaccine may allow for better global accessibility of vaccine for epidemics or future pandemics.
View PDF
Is a booster dose necessary in children after immunization with live attenuated Japanese encephalitis vaccine?
TLDR
It is predicted that immunity will be maintained for a long time by an amnestic response after a booster vaccination with live attenuated vaccine.
View on PubMed
Etiology of Invasive Bacterial Infections in Immunocompetent Children in Korea (1996-2005): A Retrospective Multicenter Study
TLDR
S. agalactiae, S. pneumoniae, and S. aureus are important pathogens responsible for invasive bacterial infections in Korean children.
View PDF
Epidemiologic picture of Kawasaki disease in Korea, 2000–2002
Background : The aim of this study was to investigate the incidence rate and epidemiologic patterns of Kawasaki disease in Korea for a 3 year period during 2000 to 2002.
View on Wiley
A randomized study of the immunogenicity and safety of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in comparison with SA14-14-2 Vaccine in children in the Republic of Korea
TLDR
A single dose of JE-CV or SA14–14–2 vaccine elicited a comparable immune response with a good safety profile and results obtained in healthy Korean children aged 12−24 months are consistent with those obtained in previous studies conducted with Je-CV in toddlers.
View on Taylor & Francis
Immunogenicity, reactogenicity and safety of a human rotavirus vaccine (RIX4414) in Korean infants: A randomized, double-blind, placebo-controlled, phase IV study
TLDR
The two-dose regimen of RIX4414 was observed to be immunogenic with a similar safety profile as compared with the placebo group, when administered to healthy Korean infants.
View on Taylor & Francis
Adjuvant laboratory marker of Kawasaki disease; NT-pro-BNP or hs-CRP?
TLDR
It is indicated that NT-pro-BNP might be a more useful laboratory marker as an adjuvant diagnostic tool for KD than hs-CRP.
View on PubMed
...
...
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License